VisionGate Presents at the World Conference on Lung Cancer for 2018 in Toronto: Malignancy Associated Change and The LuCED® Test for Detection of Early Stage Lung Cancer
Breakthrough Research to be Presented at the 2018 World Conference on Lung Cancer SEATTLE, WA (September 24, 2018) – VisionGate, a clinical stage oncology pharmaceutical and diagnostics company announces two peer-reviewed poster presentations [...]